Bette Caan to Postmenopause
This is a "connection" page, showing publications Bette Caan has written about Postmenopause.
Connection Strength
5.436
-
Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes: a placebo-controlled randomized trial. Menopause. 2015 Jun; 22(6):607-15.
Score: 0.411
-
Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA. 2010 Oct 20; 304(15):1684-92.
Score: 0.299
-
Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst. 2008 Apr 16; 100(8):597-8; author reply 599.
Score: 0.251
-
Calcium plus vitamin D supplementation and the risk of postmenopausal weight gain. Arch Intern Med. 2007 May 14; 167(9):893-902.
Score: 0.235
-
Examining the relationship between D3Cr muscle mass, physical performance, and functional limitation in postmenopausal women. J Gerontol A Biol Sci Med Sci. 2026 Sep 05; 81(10).
Score: 0.224
-
DXA-Derived Abdominal Adiposity and Obesity-Related Cancer Risk Among Postmenopausal Women in the Women's Health Initiative. Obesity (Silver Spring). 2026 May; 34(5):997-1009.
Score: 0.217
-
DXA-Derived Visceral and Subcutaneous Adipose Tissue and Postmenopausal Breast Cancer Mortality. Curr Oncol. 2026 Feb 17; 33(2).
Score: 0.216
-
Dual-energy X-ray Absorptiometry-Derived Adiposity and Colorectal Cancer Incidence and Mortality in Postmenopausal Women. Cancer Epidemiol Biomarkers Prev. 2025 Oct 03; 34(10):1801-1809.
Score: 0.211
-
Association of Prediagnostic Frailty, Change in Frailty Status, and Mortality After Cancer Diagnosis in the Women's Health Initiative. JAMA Netw Open. 2020 09 01; 3(9):e2016747.
Score: 0.148
-
Prediagnosis social support, social integration, living status, and colorectal cancer mortality in postmenopausal women from the women's health initiative. Cancer. 2020 04 15; 126(8):1766-1775.
Score: 0.142
-
It's Absolutely Relative: The Effect of Age on the BMI-Mortality Relationship in Postmenopausal Women. Obesity (Silver Spring). 2020 01; 28(1):171-177.
Score: 0.141
-
The Effects of Reverse Causality and Selective Attrition on the Relationship Between Body Mass Index and Mortality in Postmenopausal Women. Am J Epidemiol. 2019 10 01; 188(10):1838-1848.
Score: 0.139
-
Stratified Probabilistic Bias Analysis for Body Mass Index-related Exposure Misclassification in Postmenopausal Women. Epidemiology. 2018 09; 29(5):604-613.
Score: 0.129
-
Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Arch Intern Med. 2008 Jul 28; 168(14):1500-11.
Score: 0.128
-
Efficacy of Vaginal Estradiol or Vaginal Moisturizer vs Placebo for Treating Postmenopausal Vulvovaginal Symptoms: A Randomized Clinical Trial. JAMA Intern Med. 2018 05 01; 178(5):681-690.
Score: 0.126
-
Dual energy X-ray absorptiometry spine scans to determine abdominal fat in postmenopausal women. Am J Hum Biol. 2016 11; 28(6):918-926.
Score: 0.111
-
Is heart rate variability associated with frequency and intensity of vasomotor symptoms among healthy perimenopausal and postmenopausal women? Clin Auton Res. 2016 Feb; 26(1):7-13.
Score: 0.107
-
Risk of Mortality According to Body Mass Index and Body Composition Among Postmenopausal Women. Am J Epidemiol. 2015 Oct 01; 182(7):585-96.
Score: 0.105
-
Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials. JAMA Oncol. 2015 Aug; 1(5):611-21.
Score: 0.104
-
Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med. 2005 Mar 14; 165(5):500-8.
Score: 0.101
-
Efficacy of exercise for menopausal symptoms: a randomized controlled trial. Menopause. 2014 Apr; 21(4):330-8.
Score: 0.095
-
African American race but not genome-wide ancestry is negatively associated with atrial fibrillation among postmenopausal women in the Women's Health Initiative. Am Heart J. 2013 Sep; 166(3):566-72.
Score: 0.091
-
A low-fat dietary pattern and risk of metabolic syndrome in postmenopausal women: the Women's Health Initiative. Metabolism. 2012 Nov; 61(11):1572-81.
Score: 0.083
-
Social networks, social support and burden in relationships, and mortality after breast cancer diagnosis. Breast Cancer Res Treat. 2012 May; 133(1):375-85.
Score: 0.082
-
Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol. 2010 Oct 10; 28(29):4410-6.
Score: 0.074
-
Migraine history and breast cancer risk among postmenopausal women. J Clin Oncol. 2010 Feb 20; 28(6):1005-10.
Score: 0.071
-
Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer. Int J Cancer. 2009 Dec 01; 125(11):2704-10.
Score: 0.070
-
Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancer. Cancer Epidemiol Biomarkers Prev. 2009 Nov; 18(11):3079-85.
Score: 0.070
-
Vasomotor symptoms, adoption of a low-fat dietary pattern, and risk of invasive breast cancer: a secondary analysis of the Women's Health Initiative randomized controlled dietary modification trial. J Clin Oncol. 2009 Sep 20; 27(27):4500-7.
Score: 0.069
-
Longitudinal study of serum carotenoid, retinol, and tocopherol concentrations in relation to breast cancer risk among postmenopausal women. Am J Clin Nutr. 2009 Jul; 90(1):162-9.
Score: 0.068
-
Biomarker-calibrated energy and protein consumption and increased cancer risk among postmenopausal women. Am J Epidemiol. 2009 Apr 15; 169(8):977-89.
Score: 0.067
-
Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst. 2008 Nov 19; 100(22):1581-91.
Score: 0.065
-
Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer. Cancer Causes Control. 2008 Dec; 19(10):1319-28.
Score: 0.064
-
Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease. Am J Epidemiol. 2006 Apr 01; 163(7):589-99.
Score: 0.054
-
A protocol for remote collection of skeletal muscle mass via D3-creatine dilution in community-dwelling postmenopausal women from the Women's Health Initiative. PLoS One. 2024; 19(4):e0300140.
Score: 0.048
-
Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med. 2004 Mar 04; 350(10):991-1004.
Score: 0.047
-
Alignment of Dietary Patterns With the Dietary Guidelines for Americans 2015-2020 and Risk of All-Cause and Cause-Specific Mortality in the Women's Health Initiative Observational Study. Am J Epidemiol. 2021 05 04; 190(5):886-892.
Score: 0.039
-
Correlates of serum alpha- and gamma-tocopherol in the Women's Health Initiative. Ann Epidemiol. 2001 Feb; 11(2):136-44.
Score: 0.038
-
Sustained Weight Loss and Risk of Breast Cancer in Women 50 Years and Older: A Pooled Analysis of Prospective Data. J Natl Cancer Inst. 2020 09 01; 112(9):929-937.
Score: 0.037
-
Response to Comment on "Bariatric Surgery is Associated With Reduced Risk of Breast Cancer in Both Premenopausal and Postmenopausal Women". Ann Surg. 2020 02; 271(2):e19-e20.
Score: 0.036
-
Association of Normal-Weight Central Obesity With All-Cause and Cause-Specific Mortality Among Postmenopausal Women. JAMA Netw Open. 2019 07 03; 2(7):e197337.
Score: 0.034
-
Facebook advertising for recruitment of midlife women with bothersome vaginal symptoms: A pilot study. Clin Trials. 2019 10; 16(5):476-480.
Score: 0.034
-
Effect of depression before breast cancer diagnosis on mortality among postmenopausal women. Cancer. 2017 Aug 15; 123(16):3107-3115.
Score: 0.029
-
Effects of Yoga and Aerobic Exercise on Actigraphic Sleep Parameters in Menopausal Women with Hot Flashes. J Clin Sleep Med. 2017 01 15; 13(1):11-18.
Score: 0.029
-
Weight Fluctuation and Cancer Risk in Postmenopausal Women: The Women's Health Initiative. Cancer Epidemiol Biomarkers Prev. 2017 05; 26(5):779-786.
Score: 0.029
-
Association between dietary inflammatory potential and breast cancer incidence and death: results from the Women's Health Initiative. Br J Cancer. 2016 05 24; 114(11):1277-85.
Score: 0.027
-
Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA. 2006 Jan 04; 295(1):39-49.
Score: 0.027
-
Pooled Analysis of Six Pharmacologic and Nonpharmacologic Interventions for Vasomotor Symptoms. Obstet Gynecol. 2015 Aug; 126(2):413-22.
Score: 0.026
-
The association between dietary inflammatory index and risk of colorectal cancer among postmenopausal women: results from the Women's Health Initiative. Cancer Causes Control. 2015 Mar; 26(3):399-408.
Score: 0.025
-
Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial. Menopause. 2014 Apr; 21(4):347-54.
Score: 0.024
-
Better postdiagnosis diet quality is associated with reduced risk of death among postmenopausal women with invasive breast cancer in the women's health initiative. Cancer Epidemiol Biomarkers Prev. 2014 Apr; 23(4):575-83.
Score: 0.023
-
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002 Jul 17; 288(3):321-33.
Score: 0.021
-
The effect of calcium plus vitamin D on risk for invasive cancer: results of the Women's Health Initiative (WHI) calcium plus vitamin D randomized clinical trial. Nutr Cancer. 2011; 63(6):827-41.
Score: 0.020
-
Calcium/vitamin D supplementation and coronary artery calcification in the Women's Health Initiative. Menopause. 2010 Jul; 17(4):683-91.
Score: 0.018
-
Variation in the FGFR2 gene and the effect of a low-fat dietary pattern on invasive breast cancer. Cancer Epidemiol Biomarkers Prev. 2010 Jan; 19(1):74-9.
Score: 0.018
-
Dietary carbohydrate, glycemic index, and glycemic load in relation to colorectal cancer risk in the Women's Health Initiative. Cancer Causes Control. 2008 Dec; 19(10):1291-8.
Score: 0.016
-
Low-fat dietary pattern and risk of benign proliferative breast disease: a randomized, controlled dietary modification trial. Cancer Prev Res (Phila). 2008 Sep; 1(4):275-84.
Score: 0.016
-
Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. Am J Epidemiol. 2008 May 15; 167(10):1247-59.
Score: 0.016
-
Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials. 1998 Feb; 19(1):61-109.
Score: 0.015
-
Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. J Natl Cancer Inst. 2007 Oct 17; 99(20):1534-43.
Score: 0.015
-
Development of a glycemic index database for food frequency questionnaires used in epidemiologic studies. J Nutr. 2006 Jun; 136(6):1604-9.
Score: 0.014
-
Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation. 2006 May 23; 113(20):2425-34.
Score: 0.014
-
Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA. 2006 Apr 12; 295(14):1647-57.
Score: 0.014
-
Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006 Feb 16; 354(7):669-83.
Score: 0.014
-
Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006 Feb 16; 354(7):684-96.
Score: 0.014
-
Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative. Arch Intern Med. 2006 Feb 13; 166(3):357-65.
Score: 0.013
-
Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006 Feb 08; 295(6):629-42.
Score: 0.013
-
Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006 Feb 08; 295(6):643-54.
Score: 0.013
-
Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006 Feb 08; 295(6):655-66.
Score: 0.013
-
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004 Apr 14; 291(14):1701-12.
Score: 0.012
-
Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. J Am Diet Assoc. 2003 Apr; 103(4):454-60.
Score: 0.011
-
Hormone replacement therapy and colorectal adenoma recurrence among women in the Polyp Prevention Trial. J Natl Cancer Inst. 2001 Dec 05; 93(23):1799-805.
Score: 0.010
-
Hormone replacement therapy and improved survival among postmenopausal women diagnosed with colon cancer (USA). Cancer Causes Control. 1999 Oct; 10(5):467-73.
Score: 0.009